Penningtons Manches Cooper acts for Stanford Capital and SI Capital on £1.145 million fundraising

Posted: 31/03/2021

The corporate team at Penningtons Manches Cooper has advised Stanford Capital (lead broker and joint placing agent) and SI Capital (joint placing agent) in relation to a £1.145 million fundraising by Incanthera plc (AQSE: INC).

The net proceeds will be used to extend Incanthera’s existing cash runway into the second half of 2022 and provides funds for the company to progress discussions in respect of a potential commercial deal for its lead asset from a strong financial position.

Incanthera works on revolutionary cancer therapies and successfully floated on AQSE on 28 February 2020, raising funds to concentrate on the commercialisation of its lead asset Sol, a proprietary topical formulation designed to deliver into the skin an active known to treat solar keratosis and prevent the formation of skin cancers.

London-based corporate partner, Seb Orton, led on this deal with assistance from associate Hannah Shamsolmaali.

Return to news headlines